Riskpilot← Back to searchSign inGet full accessLERVIGSVEIEN BOLIG AS
ASActiveOrg 916766076Lilleakerveien 8, 0283 OsloDevelopment of building projects · NACE 6812Est. 20160 employees
Revenue 2024
NOK 49,4M
-79% vs 2023
EBITDA margin
22.0%
+15% vs 2023
Equity ratio
1.5%
Financial strength
Net profit 2024
NOK 9,3M
+24% vs 2023
| Revenue | NOK 49,4M | -79% |
| EBITDA | NOK 10,9M | +15% |
| Net profit | NOK 9,3M | +24% |
| Total assets | NOK 72,3M | -88% |
| Equity | NOK 1,1M | -96% |
| Employees | 0 | — |
Legal name
LERVIGSVEIEN BOLIG AS
Org number
916766076
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
18. februar 2016
Share capital
NOK 655 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Erverve, utvikle, drive og avhende fast eiendom, samt all annen naturlig tilhørende virksomhet. Selskapet kan eie aksjer i andre selskaper.
Address
Lilleakerveien 8, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 500 | 13 136 | 215 075 | 232 778 | 49 441 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −456 | 1 284 | 11 763 | 9 428 | 10 854 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −456 | 1 284 | 11 763 | 9 428 | 10 854 |
| Net financials | 27 | 36 | 95 | 212 | 1 324 |
| Profit before tax | −430 | 1 320 | 11 858 | 9 640 | 12 178 |
| Tax | −95 | 454 | 2 609 | 2 121 | 2 844 |
| Net profit | −335 | 866 | 9 249 | 7 519 | 9 334 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 78 339 | 117 535 | 369 016 | 589 140 | 72 349 |
| Equity | 11 622 | 12 488 | 21 738 | 28 916 | 1 070 |
| Long-term debt | 34 500 | 317 | 2 926 | 5 046 | 0 |
| Short-term debt | 32 216 | 104 730 | 344 353 | 555 178 | 71 279 |
| Total debt | 66 716 | 105 047 | 347 278 | 560 225 | 71 279 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20202024
Equity ratio
1.5%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
872.0%
This company
18.4%
Market median
+4639% vs market
20202024
Net profit margin
18.9%
This company
8.1%
Market median
+133% vs market
20202024
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20202024
Debt / equity
66.59×
This company
0.62×
Market median
-10640% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ES Chief Executive Officer | Chief Executive Officer | 2017 |
LL Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
LH Deputy Member | Deputy Member | 2018 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 65% | 65% | 2023 | |
| Company | 35% | 35% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Leif Hübert As
LERVIGSVEIEN BOLIG AS Board members of LERVIGSVEIEN BOLIG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif Hübert | Deputy Member | 0 companies |
| Einar Stokke Amundsen | Chief Executive Officer | 0 companies |
| Lasse Lundhaug | Chief Executive Officer | 0 companies |
| Henrik Schüssler | Board of Directors | 0 companies |
| Jostein Devold | Board of Directors | 0 companies |